Posts Tagged ‘Switzerland’
Superlab Suisse Lausanne
A coworking space designed for scientists Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in laboratory spaces. Superlab Suisse’s «Lab as a Service» business concept includes innovatively designed laboratory facilities, state-of-the-art equipment, professional and concierge services, as well as financing support for companies in the biotech, pharma, and medtech sectors.…
Read More$11 million for EPFL spin-off Leman Biotech
A protein that boosts the immune system can cure 90% of cancer in mice Immunotherapy, which aims to boost the patient’s immune system to fight cancer, has no effect in two out of three cases. After a while, T lymphocytes, the main players against cancer cells, become exhausted. To give them a new lease…
Read MoreNeo Medical raises $20 million for its AR technology for spine surgery
Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the commercial deployment of its artificial intelligence-supported augmented reality platform for spinal surgery. With a focus on the US market. Called Advise, the technology “provides surgeons with real-time intraoperative augmented reality (AR) visibility for the first…
Read MoreINTERVIEW : Massimo Nobile
🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.
Read MoreMindMaze secures a $105 million financing round
After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital Association Partnership MindMaze is a pioneer in the multibillion-dollar digital neurotherapeutics market and develops therapeutic solutions for a wide spectrum of neurological diseases. The financing was led by Concord Health Partners (“Concord”), a US-based…
Read MoreLeucine project: a new hub for life sciences in Lausanne
New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new multi-tenant space for companies active in life sciences. It will be operational early 2023. It consists of laboratory and office space that can be customised to its tenants’ needs. Three full floors of up to…
Read MoreINTERVIEW : Raphaël Conz, BioAlps vice-president
🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of the Canton of Vaud (SPE). The talent of Switzerland, in the field of life sciences, is to bring together academic research and big companies’ interests.
Read MoreINTERVIEW : Claude Clément, BioAlps President
🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the field of life sciences.
Read MoreScience first, politics second
The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme. The Stick to Science initiative has been set up by a coalition of 140 British universities and by the Polytechnic schools of Lausanne and Zurich (EPFL and EPFZ). They are calling for open and barrier-free collaboration…
Read MoreAn implant could cure paralysis
A new implant enables patients with a complete spinal cord injury to stand, walk and even swim Michel Roccati, an Italian patient suffering from complete paraplegia following a motorcycle accident, was able to walk again thanks to an implant placed against his spinal cord. Grégoire Courtine, neuroscientist and professor at the EPFL, and Jocelyne…
Read More